Extremity immobilisation system helps low dose radiotherapy gain traction

Low dose radiotherapy (LDRT) is gaining renewed attention in the UK as a treatment option for selected benign and inflammatory conditions. By delivering carefully controlled radiation doses, clinicians can achieve meaningful symptom relief – often improving mobility, comfort and overall quality of life – for a large subset of patients, while maintaining a favourable tolerability profile, according to patient positioning device manufacturer CDR Systems.

As national guidance and clinical experience continue to mature, UK providers such as GenesisCare are expanding access to structured, protocol-driven LDRT programmes. Many LDRT applications involve non-conventional anatomy, positioning requirements, and treatment workflows that differ significantly from standard oncology set-ups. Achieving reproducibility, efficiency and consistency across fractions and clinical teams is therefore a critical operational challenge.

CDR Systems supports the GenesisCare LDRT programme with its ExtremityLock positioning products, designed to address the unique challenges of LDRT by enabling stable, repeatable positioning of extremities and other anatomies that fall outside conventional radiotherapy set-ups.

The ExtremityLock range is engineered to integrate into varied clinical workflows and margin strategies, helping teams standardise complex set-ups while maintaining efficiency and precision. By focusing on systems and methods rather than stand-alone devices, CDR Systems supports reproducibility across staff, shifts and treatment sessions.

Picture: shielding healthy tissue is a common method for LDRT of the hand.

Read this report on page 14 of the January 2026 issue of RAD Magazine.